CD4 and cancer: The TIDE analysis highlighted specific immune cell changes associated with responders, including an increase in CD4+ TILs (P < 0.05) and macrophages (P < 0.05), and a concurrent decrease in cancer-associated fibroblasts (CAFs, P < 0.01) and endothelial cells (P < 0.01) (Supplemental Data 7).